Currently, 81.5% of patients with embryo implantation failures (no implantation despite several high-quality embryos transferred) have dysregulation in their immunity environment in the endometrial area. Our laboratory helps women with implantation failures, but also those with miscarriages, through immunity testing of their uterine receptivity (from an endometrial biopsy).
According to the results of our survey in 2016, 86% of patients questioned found this exam to be useful.
We analyse the number and activity of the Natural Killer (uNK) uterine cells, cells in the immune system which play an essential role in embryo implants.
RESEARCH AND DEVELOPMENT
Working in this research area, the MatriceLAB Innove team concentrates its efforts on embryo-maternal dialogue. In addition to immunity receptivity analyses, we pursue activities in our company’s research and development. We currently have several projects under way.
OUR PATIENTS’ BENEFITS
MatriceLAB Innove is a reproduction R&D laboratory created at the end of 2011 by Dr Nathalie Lédée (MD, PhD).
The laboratory benefited from the support of Paris Biotech Santé, an incubator of innovative companies specialised in the development of medicines, medical devices and innovative services which benefit patients.